Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence

AIM: To evaluate the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) versus comparator regimens for type 2 diabetes in Spain, based on real‐world evidence. MATERIALS AND METHODS: Clinical data were taken from the European Xultophy Treatment Retrospecti...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diabetes Obes Metab
Hoofdauteurs: Raya, Pedro Mezquita, Blasco, Francisco Javier Ampudia, Hunt, Barnaby, Martin, Virginia, Thorsted, Brian Larsen, Basse, Amaury, Price, Hermione
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Blackwell Publishing Ltd 2019
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594226/
https://ncbi.nlm.nih.gov/pubmed/30740861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13660
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items